List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 38 studies with search of: Open Studies | "Cytomegalovirus Infections"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
Conditions: Disorder of Transplanted Kidney;   Cytomegalovirus Infections
Intervention:
2 Not yet recruiting Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
Conditions: Cytomegalovirus Infection;   Preterm Infants
Intervention: Procedure: ultrashort heat inactivation
3 Not yet recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
4 Recruiting Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
Condition: Cytomegalovirus Infection
Intervention:
5 Recruiting Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
Condition: Cytomegalovirus Disease
Interventions: Drug: Valganciclovir;   Biological: CMV hyperimmune globulin
6 Recruiting Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV-Peptide-Specific T cells
7 Recruiting Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Condition: Cytomegalovirus Disease
Interventions: Drug: Certican (everolimus) + valganciclovir;   Drug: Valganciclovir
8 Not yet recruiting The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
Condition: Cytomegalovirus Infections
Intervention:
9 Unknown † Genotyping of Cytomegalovirus From Patients in Israel
Condition: Cytomegalovirus Infections
Intervention:
10 Unknown † Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
Condition: Cytomegalovirus Infection
Intervention: Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
11 Recruiting Evaluation of the Artus® CMV PCR Test
Condition: Cytomegalovirus Infections
Intervention:
12 Recruiting Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
Conditions: Stem Cell Transplantation;   Cytomegalovirus Infections
Intervention: Biological: CMV CTL infusion
13 Recruiting Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus
Conditions: Cytomegalovirus Infections;   Adenovirus Infections
Intervention: Other: Cell therapy
14 Unknown † Cytomegalovirus (CMV) Infection in Amniotic Fluid
Conditions: Pregnancy Complications;   Cytomegalovirus Infections
Intervention:
15 Unknown † Cytomegalovirus Cell-Mediated Immunity
Condition: Cytomegalovirus Infections
Intervention:
16 Not yet recruiting Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV Specific T Cell donor lymphocyte infusion
17 Recruiting Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
Conditions: Heart Transplantation;   Cardiac Allograft Vasculopathy;   Cytomegalovirus Infection
Interventions: Drug: Pre-emptive strategy with valganciclovir plus everolimus;   Drug: Prophylaxis with valganciclovir plus mycophenolate;   Drug: Prophylaxis with valganciclovir plus everolimus;   Drug: Pre-emptive mycophenolate
18 Recruiting A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients
Condition: Cytomegalovirus Infections, Kidney Transplantation
Intervention: Drug: valganciclovir [Valcyte]
19 Recruiting A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Condition: Cytomegalovirus Infections, Heart Transplantation
Intervention: Drug: valganciclovir [Valcyte]
20 Recruiting Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Conditions: Infections, Cytomegalovirus;   Transmission of Cytomegalovirus Infection From Pregnant Woman to Foetus
Interventions: Procedure: Blood sample;   Procedure: Cord blood sample;   Procedure: Saliva swab;   Procedure: Urine sampling;   Procedure: Vaginal swab

Previous Page Studies Shown (1-20) Next Page (21-38)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services